Obesity or Overweight GLP-1 medications are particularly beneficial for individuals who are overweight or obese, as they can help promote weight loss in addition to improving blood sugar control
Common genetic variants in detoxification and response genes such as CYP1A2, CYP3A4, GSTM1, GSTA1, GSTP1, UGT1A1, XPC, GSDMB, and IL13 can increase susceptibility to mitochondrial damage, organ injury, or asthma from mycotoxins
It is effective for up to three years
While this is a very large study which followed patients for a long time, we cant yet know the potential impact of sustained use of medications like these, especially in cardiovascular patients who are not living with overweight and obesity
Its the only one in the U.S
And dont forget the wealth effect: Hang Seng Index climbed almost 30 percent in 2025